Back to search
FDAFDA · Food and drugs·Recall number D-1440-2012

Xactdose Phenytoin Oral Suspension, USP 125 mg/5mL, supplied in 5 mL unit dose cups, VISTAPHARM, Largo, FL NDC 66689-036-50

Published August 8, 2012 · Recall initiated: September 30, 2011

Summary

FDA records drug Class II recall D-1440-2012, published August 8, 2012 and initiated September 30, 2011. Recalling firm: VistaPharm, Inc.; Status: Terminated; Reported quantity: 27,221 unit dose cups; Lot: Lot #'s 210900, 214000, 220100, 224800, 228700, 232800. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
VistaPharm, Inc.
Distributor
Nationwide
Lot
Lot #'s 210900, 214000, 220100, 224800, 228700, 232800
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Xactdose Phenytoin Oral Suspension, USP 125 mg/5mL, supplied in 5 mL unit dose cups, VISTAPHARM, Largo, FL NDC 66689-036-50 recalled?

Yes. FDA published recall D-1440-2012 on August 8, 2012. Reported hazard: Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume.

What should I do if I have this product?

Voluntary: Firm initiated · Letter